PP-078 Activation of immune cells against influenza virus by the viral epitope fused to protein transduction domain of Tat of HIV  by Kumar, P. et al.
S48 Abstracts, 4th DICID
Results: The NA gene was successfully expressed in Sf9
insect cell. The recombinant his-NA protein was expressed
in the insect cells with a relative molecular mass of 52 kDa.
Western blotting demonstrated that the recombinant his-
NA could be recognized and bound by anti-his monoclonal
antibody and the convalescent sera of patients who have
recovered from S-OIV infection.
Conclusion: Our results indicated that the recombinant
neuraminidase with a post-translation modiﬁcation was
successfully expressed obtained in insect cells, which
might provide a potential resource for further study of
its biological function.
PP-076 The distribution of pathogens in ICU patients
with serious H1N1 inﬂuenza A infection at
lower respiratory tract and bacteria resistant
analysis
B.M. Chen1 *, L.H. Song1, J.J. Li1. 1Beijing Ditan hospital,
China
Background: To understand the distribution of pathogens
in ICU patients with serious H1N1 inﬂuenza A infection at
lower respiratory tract and bacteria resistant analysis, in
order to ﬁnd better way for prevention from its infection.
Methods: Bacteriological analysis of sputum was done from
patients with serious H1N1 inﬂuenza A at our ICU from
Oct. 2009 to Jan. 2010 using BD100 Microbial Identiﬁcation
Analyzer.
Result: 37 out of 50 cases with serious H1NI inﬂuenza A were
suffered from lower respiratory tract bacterial infection.
Infection rate was 74%. 15 cases died, mortality rate
was 30% (15/50). 58 pathogenic strains were isolated
from sputum of 50 patients. First of ranking was
G( ) bacillus with 26 strains (44.8%), followed by fungi
16 (27.6%), then G(+) coccus 12 (20.7%), G( ) coccus
4 (6.9%). The top four in order among G( ) bacillus were
Acinetobacter baumannii [9 strains, accounted for 34.6% in
G( )], Stenotrophomonas maltophilia (4, 15.4%), Klebsiella
(4, 15.4%) and Escherichia coli (2, 7.7%). Most fungi
detected were Candida albicans (12 strains, 75%), followed
by Aspergillus fumigatus (4, 25%). Enterococcus ranked
ﬁrst, followed by Staphylococcus. There were 4 Moraxella
catarrhalis of G( ) cocci. 1 out of 3 Staphylococcus was
MRSA. 9 strains Acinetobacter baumannii were all pan-
resistant. 1 out of 4 Klebsiella produced ESBL (+). 1 out of 2
Escherichia coli produced ESBL (+). Susceptibility test
indicated that all Acinetobacter baumannii were sensitive
only to polymyxin; Stenotrophomonas maltophilia only
sensitive to levoﬂoxacin and sulfamethoxazole; Moraxella
catarrhalis sensitive only to Tulathromycin.
Conclusion: Lower respiratory tract infections in ICU
patients with serious H1NI inﬂuenza A were caught mainly
by Acinetobacter baumannii, Candida albicans, Moraxella
catarrhalis respectively. Therefore, strengthening health
care hand hygiene and enhancing standard protection, using
antibiotics rationally, doing correct clinical work for ICU
patients in preventing and controlling lower respiratory
tract infection is all extremely important.
PP-077 Risk factors associated with severe inﬂuenza in
tropical Singapore
S. Sandar1 *, A. Chow1, D. Lye2, T. Barkham3, Y.-S. Leo2.
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Objectives: Inﬂuenza circulates year-round in tropical
Singapore. However, the burden of inﬂuenza remains under-
appreciated. We aim to identify risk factors associated with
severe inﬂuenza in patients admitted to a 1,200-bedded
adult tertiary-care hospital.
Methods: Patients with respiratory samples tested positive
for inﬂuenza, via polymerase chain reaction (PCR), within 48
hours of hospitalisation, were included in the study. Socio-
demographic, clinical, and laboratory data were collected
via retrospective case review.
Results: From January to December 2008, 205 patients had
a positive inﬂuenza PCR test. Of these, 37 (18%) had severe
inﬂuenza (admission to an intensive care unit or death).
On univariate analysis, age 65 years (Odds ratio[OR] 2.2,
95% Conﬁdence Interval[CI] 1.0 5.1), presence of a pre-
existing medical condition (OR 1.9, 95%CI 0.8 5.5), and
clinical features of altered mentation (OR 17.1, 95%CI
6.5 45.0), hypotension (systolic blood pressure <90 mmHg)
(OR 2.8, 95%CI 1.0 7.8), tachycardia (pulse rate >100/min)
(OR 3.4, 95%CI 1.4 9.0), and poor oxygen saturation <90%
(OR 11.3, 95%CI 2.8 53.7) at presentation to hospital, were
signiﬁcantly associated with severe inﬂuenza. However,
patients with severe illness were less likely to present with
fever (OR 0.1, 95%CI 0.1 0.3), and respiratory symptoms
(OR 0.1, 95%CI 0 0.2) than those without. On multivariate
analysis, a medical history of hypertension (OR 3.0, 95%CI
1.4 6.4), myocardial infarction (OR 3.5, 95%CI 1.2 9.7),
and malignant solid tumour (OR 3.8, 95%CI 1.1 13.0),
and an altered mentation (OR 14.8, 95%CI 5.1 42.9) were
independent risk factors for severe inﬂuenza.
Conclusion: Patients with hypertension, myocardial
infarction, malignant solid tumour, and those who presented
with an altered mentation, were at increased risk of severe
inﬂuenza. Inﬂuenza vaccination is strongly encouraged in
patients with such underlying medical conditions. Patients
with altered mentation should also be closely monitored for
severe illness.
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virus by the viral epitope fused to protein
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Background: Inﬂuenza viruses continue to pose a severe
threat worldwide, causing thousands of deaths and
enormous socio-economic loss. The major problem in
ﬁghting inﬂuenza virus is the high genetic variability
which allows the virus to infect new host species and
quickly overcome protective immunity. Vaccination with
viral epitope, conserved in all the types and sub-types of
inﬂuenza A virus, may counter the virus infection.
Methods: The study was carried out in which the protein
transduction domain (PTD) of Tat protein of human
immunodeﬁciency virus (HIV) was fused to the epitopic
segment of the matrix gene of inﬂuenza A virus as the
PTD domain is known to deliver the peptides 10 kDa
into the eukaryotic cells without the assistance of any
external agent. The fused oligo was cloned in pSecTag2A and
expressed in MDCK cell line. The fusion protein was isolated,
puriﬁed and expressed on antigen presenting cells (APCs) to
generate immune response against the virus infected cells.
Results: We have shown that the APCs expressing the
fusion protein generated the cytotoxic T lymphocytes (CTLs)
when co-incubated with the cultured naive T cells. When
the sensitized APCs were given intra-peritoneally (i.p.) in
Balb/c mouse and further instilled with inﬂuenza A virus
[A/PR/8/34 (H1N1)], reduced viral plaque count in lung
tissues was observed. The real time RT PCR assay also
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showed the decrease in viral titer as compared to the mock
infected mouse.
Conclusion: Thus, this strategy represents a versatile
system as a single carrier protein could be easily and
rapidly coupled to the desired peptide to sensitize the
APCs and thus activate the host immune system against the
pathogenic virus.
PP-079 Clinical characteristics and treatment of 27
cases of H1N1 inﬂuenza
B. Zhou1, Y.P. Zhou1 *, W. Li1, S.L. Yang1, R.L. Jiang1,
D.L. Liu1, F.Y. Zhou1, J.L. Hou1. 1Department of Infectious
Diseases, Nanfang Hospital, Southern Medical University,
Guangzhou 510515, China
Objective: To explore the pandemic characteristics and
effective treatment measures of H1N1 inﬂuenza.
Methods: A total of 27 patients diagnosed as H1N1 inﬂuenza
from Nanfang hospital (from November 2009 to February
2010) were analyzed.
Results: The study included 15 Males and 12 females aged
from 5 to 63 years (average:29.1). From 27 patients,
16 (59.3%) had different parimary disease. The most
common symptoms were fever (96.3%), cough (81.5%),
dyspnea (59.3%), pneumonia or bronchitis (55.6%)
and pharynx pain (44.4%). Other complications, such
as renal impairment (13.3%), severe gastrointestinal
symptoms (6.7%) and change of consciousness (7.4%), were
found in some patients. Fever period of 12 severe patients
with primary disease was 5 17 (10.6±384) days. A series
of measures like antiviral, antibacterial, management of
the respiratory tract and Glucocorticoids Ictus therapies
were taken according to patients’ conditions. For the 27
patients studied, 22 (81.5%) were cured, and 5 (18.5%)
died. Of 5 cases dead, 4 had serious primary diseases and
only 1 died from H1N1. No case of nosocomial infection was
found in the study.
Conclusion: The complication of pneumonia was more
frequently appeared in severe patients with inﬂuenza H1N1.
Most patients could be cured by positive and effective
measures. However, the mortality rate of serious patients
with primary diseases was still high.
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PP-080 Epidemiological study and clinical analysis of
patients with hand, foot and mouth disease in
eastern Zhejiang province in the past 3 years
A.-R. Hu1 *, X.-Y. Liang1, W.-Y. Xuan1, D.-Z. Li1. 1Ningbo
Infectious Diseases Hospital, China
Objective: To explore the epidemiological and clinical
characteristics of patients with hand, foot and mouth
disease (HFMD) in eastern Zhejiang province from March
2007 to August 2009.
Methods: The distribution of gender, age, time of onset,
region and clinical data were analyzed by descriptive
epidemiological methods.
Results: A high incidence of HFMD occurred mostly in
infants aged below 4 years (95.9%), especially aged 1 to
3 years (82.6%). Males were more likely to acquire the
disease than females, and the ratio was 1.7:1. Onset of
HFMD was most in April to July, but the peak incidence in
2009 (April) was earlier than in 2008 (May and June). People
living in the district and county-level city of population
density and foreign population were more likely to acquire
the disease. Typical clinical presentations included fever
and characteristic rashes, and the incidence rate of rashes
was up to 97.77%. Characteristics of the rashes were
painless rashes which located in hand, foot, buttock and/or
knees and painful oral ulcers. The ratio of patients with
hyperpyrexia was 34.86%, with leukocytosis was 48.11% (but
severe cases was rare), with elevated creatine kinase (CK)
was 20.94% and elevated CK-MB was 76.28%, but abnormal
electrocardiographic (ECG) pattern was rare, with elevated
FBG was 13.36%. There were no correspondence among the
abnormal high levels of CK, CK-MB, ALT, AST and abnormal
ECG.
Conclusions: HFMD will be fully recovered in approximately
one week by conventional anti-virus treatment and
symptomatic treatment. But it also needs our intensive
care to prevent and treat various complications. Traditional
Chinese medicine has comparative advantage and should be
promoted. Except positive isolation, disease treatment and
epidemic site treatment, effective health education is also
important to disease prevention.
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Background: Hepatic Schistosomal ﬁbrosis is a continuous
process. Bacteria may reach the liver via the portal venous
blood from the intestinal tract & abnormalities in the liver
circulation could abolish the ﬁlter effect of the liver.
Aim: To determine whether bacteria are present or not, to
know its species and evaluate its role in the pathogenesis
of Schistosomal liver ﬁbrosis.
Subjects and Methods:
Group A
1. 25 patients with Schistosomal hepatic ﬁbrosis were
submitted to clinical examination & the consent was
written by each patient before splenectomy.
2. Portal pressure was measured.
3. Excisional liver biopsy was taken for histopathology
and culture.
4. 15 ml of portal blood was aspirated by veinpuncture
from the portal vein and 15 ml venous blood was
simultaneously taken from the anticubital vein.
5. Each 5 ml of the portal and venous blood were added
to 10ml of 0.05% sulphonated broth.
6. The blood broth tubes were incubated aerobicaly,
anaerobically and in 5% CO2.
Group B. Portal and systemic blood samples were taken from
6 non-bilharzial patients as control group during peptic
ulcer operations.
Results:
1. The systemic blood of all patients & the liver biopsy
cultures proved to be sterile.
2. Three portal blood samples were excluded due to
contamination.
3. 22.7% of portal blood samples from Schistosomal patients
were positive for bacteria (Staphyloccus aureus from 3
patients, Escherichia coli from one patient & Bacteroides
fragilis from one patient.
4. Samples of portal and systemic blood from controls were
sterile.
Conclusions:
1. Portal bacteraemia in Schistosomal hepatic ﬁbrosis
explains the occurrence of parenchymal involvement in
such patients by the effect of the viable bacteria or its
toxin on the hepatocytes.
